Harvard Apparatus Regenerative Technology Inc. announced that it has entered into Securities Purchase Agreements with certain investors to issue an aggregate of 367,767 shares of common stock at a purchase price of $4.03 per share for the gross proceeds of $1,482,101.01 on April 15, 2024. The shares are issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under and/or Regulation D thereunder.